Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient

NCT00842855 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00842855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00842855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
February 28, 2009
Completion date
November 30, 2010
Enrollment
275 (estimated)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disease